Antitumor Synergy With SY-1425, a Selective RARα Agonist, and Hypomethylating Agents in Retinoic Acid Receptor Pathway Activated Models of Acute Myeloid Leukemia
Haematologica - Italy
doi 10.3324/haematol.2018.192807
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 18, 2018
Authors
Publisher
Ferrata Storti Foundation (Haematologica)